NYSE$LH
Laboratory Corp Of America Holdings · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Labcorp's Q4 2020 results were announced, highlighted by significant revenue and EPS growth driven by COVID-19 testing and base business improvement.
Labcorp announced strong Q4 2020 results with a 52% increase in revenue to $4.5 billion and a significant rise in diluted EPS to $9.54, driven by COVID-19 testing and improvements in the base business. The company also provided full year 2021 guidance, expecting adjusted EPS between $19.00 and $23.00 and free cash flow between $1.7 billion and $1.9 billion.
- Revenue increased to $4.5 billion, up 52% from the previous year, driven by organic growth and COVID-19 testing.
- Diluted EPS rose to $9.54, a significant increase from $2.32 in the same quarter of the previous year.
- Adjusted EPS reached $10.56, up from $2.86 year-over-year.
- Free cash flow increased to $675 million, compared to $442 million in the prior year.
Headline financials
Revenue & EPS history
LabCorp · Revenue · Quarterly
$4.49B
Revenue by segment
LabCorp · $4.55B total across 2 segments · Q4 2020
- Diagnostics Laboratories$3.15B+79.5%69.3%
- Biopharma Laboratory Services$1.4B+16.4%30.7%
Forward guidance
Labcorp provided its outlook for 2021, including revenue growth, adjusted EPS, and free cash flow.
Tailwinds
- Total Labcorp Enterprise revenue is expected to increase by (1.0%) to 4.5%.
- Base Business revenue is projected to grow between 11.0% and 13.5%.
- Total Diagnostics revenue is anticipated to increase by (7.5%) to (0.5%).
- Total Drug Development revenue is forecasted to grow between 8.0% and 10.5%.
- Free Cash Flow is expected to be in the range of $1.7 billion to $1.9 billion.
Headwinds
- COVID-19 Testing revenue is expected to decline by (50.0%) to (35.0%).
- COVID-19 Testing revenue for Total Diagnostics is expected to decline by (50.0%) to (35.0%).
- Adjusted EPS is projected to be between $19.00 and $23.00.
- The guidance assumes foreign exchange rates effective as of December 31, 2020.
- Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions and share repurchases.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
-0.3%
Avg return
Earnings day
-0.6%
Avg return
5 days after
-0.9%
Avg return
30 days after
48%
35 / 73 earnings
Positive
+9.5%
Q2 2024
Best reaction
-10.4%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.0% | +0.0% | +1.3% | |
| Q4 2025 | -2.1% | +0.0% | -6.6% | |
| Q3 2025 | -5.7% | -7.9% | -2.7% | |
| Q2 2025 | -0.5% | +1.2% | +2.0% | |
| Q1 2025 | +4.7% | +7.9% | +7.5% | |
| Q4 2024 | -0.9% | -1.9% | +1.2% | |
| Q3 2024 | +4.0% | +3.7% | +9.0% | |
| Q2 2024 | +9.5% | +4.8% | +6.7% | |
| Q1 2024 | -4.6% | -3.2% | -4.0% | |
| Q4 2023 | -5.0% | -5.5% | -8.3% | |
| Q3 2023 | +0.6% | +1.0% | +7.6% | |
| Q2 2023 | -1.9% | -2.4% | -3.0% | |
| Q1 2023 | -4.6% | -2.5% | -8.2% | |
| Q4 2022 | +3.2% | -0.4% | -14.1% | |
| Q3 2022 | -2.5% | -3.2% | +5.0% | |
| Q2 2022 | +5.1% | +1.2% | -8.1% | |
| Q1 2022 | -5.0% | -3.1% | +1.9% | |
| Q4 2021 | -1.9% | -6.0% | -5.7% | |
| Q3 2021 | +2.3% | +2.0% | +3.1% | |
| Q2 2021 | +4.6% | +6.0% | +6.1% | |
| Q1 2021 | +1.2% | +4.1% | +4.5% | |
| Q4 2020 | +4.0% | +3.1% | +4.1% | |
| Q3 2020 | +1.0% | -1.1% | -2.7% | |
| Q2 2020 | -3.3% | -4.2% | -13.4% | |
| Q1 2020 | -6.5% | -10.4% | -0.4% | |
| Q4 2019 | +4.1% | +1.8% | -19.5% | |
| Q3 2019 | -2.0% | -2.3% | +0.4% | |
| Q2 2019 | -6.5% | -4.2% | -6.9% | |
| Q1 2019 | +3.7% | +6.1% | +5.1% | |
| Q4 2018 | +2.5% | +3.8% | +3.7% | |
| Q3 2018 | -7.1% | -6.2% | -4.1% | |
| Q2 2018 | -5.4% | -6.4% | -5.3% | |
| Q1 2018 | +3.9% | +2.8% | +9.7% | |
| Q4 2017 | +3.9% | +3.0% | +5.9% | |
| Q3 2017 | +1.7% | +2.2% | +0.2% | |
| Q2 2017 | +2.0% | +1.3% | -1.4% | |
| Q1 2017 | -4.1% | -3.1% | -1.9% | |
| Q4 2016 | +2.4% | +2.4% | +5.4% | |
| Q3 2016 | -10.4% | -9.4% | -7.9% | |
| Q2 2016 | +0.4% | +1.2% | -1.4% | |
| Q1 2016 | +4.1% | — | — | |
| Q4 2015 | +2.8% | — | — | |
| Q3 2015 | +7.8% | — | — | |
| Q2 2015 | +3.8% | — | — | |
| Q1 2015 | -2.7% | — | — | |
| Q4 2014 | +4.9% | — | — | |
| Q3 2014 | +3.5% | — | — | |
| Q2 2014 | -0.5% | — | — | |
| Q1 2014 | -0.7% | — | — | |
| Q4 2013 | +1.1% | — | — | |
| Q3 2013 | -3.2% | — | — | |
| Q2 2013 | +0.0% | — | — | |
| Q1 2013 | +0.7% | — | — | |
| Q4 2012 | -1.7% | — | — | |
| Q3 2012 | -4.0% | — | — | |
| Q2 2012 | -9.0% | — | — | |
| Q1 2012 | -3.4% | — | — | |
| Q4 2011 | +2.2% | — | — | |
| Q3 2011 | -6.6% | — | — | |
| Q2 2011 | -0.6% | — | — | |
| Q1 2011 | +1.4% | — | — | |
| Q4 2010 | -0.2% | — | — | |
| Q4 2007 | -0.2% | — | — | |
| Q3 2010 | +1.6% | — | — | |
| Q2 2010 | +0.9% | — | — | |
| Q1 2009 | +1.8% | — | — | |
| Q1 2010 | +1.6% | — | — | |
| Q4 2009 | -0.4% | — | — | |
| Q2 2008 | -1.6% | — | — | |
| Q3 2009 | -1.6% | — | — | |
| Q3 2008 | -1.6% | — | — | |
| Q4 2008 | -1.4% | — | — | |
| Q2 2009 | -1.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro